Standout Papers

Randomized Trial of Peanu... 1985 2026 1998 2012 1.3k
  1. Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy (2015)
    George Du Toit, Graham Roberts et al. New England Journal of Medicine
  2. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores (1989)
    Marshall Plaut, Jacalyn H. Pierce et al. Nature
  3. Results of a Home-Based Environmental Intervention among Urban Children with Asthma (2004)
    Wayne J. Morgan, Ellen F. Crain et al. New England Journal of Medicine
  4. Inflammatory Mediators in Late Antigen-Induced Rhinitis (1985)
    Robert M. Naclerio, David Proud et al. New England Journal of Medicine
  5. Oral Immunotherapy for Treatment of Egg Allergy in Children (2012)
    A. Wesley Burks, Stacie M. Jones et al. New England Journal of Medicine

Immediate Impact

20 by Nobel laureates 22 from Science/Nature 69 standout
Sub-graph 1 of 19

Citing Papers

A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety
2019 Standout
12 intermediate papers

Works of Marshall Plaut being referenced

Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults
2016
Summary of the 2008 National Institute of Allergy and Infectious Diseases–US Food and Drug Administration Workshop on Food Allergy Clinical Trial Design
2009
and 6 more

Author Peers

Author Last Decade Papers Cites
Marshall Plaut 5642 2830 4024 92 9.8k
Ruby Pawankar 3725 1503 3580 160 7.8k
A.B. Kay 4205 4303 7462 90 10.7k
Hans C. Oettgen 3848 5586 3790 121 10.3k
Rob C. Aalberse 5948 1584 2796 185 11.1k
S. G. O. Johansson 5330 1076 3022 127 8.3k
Anne Kagey‐Sobotka 5673 2912 4705 166 9.5k
Roger Lauener 2394 2658 4001 122 8.5k
Lanny J. Rosenwasser 2133 3652 3564 183 9.3k
Eckard Hamelmann 3290 3320 6221 249 10.4k
David G. Marsh 4618 1656 3722 188 7.9k

All Works

Loading papers...

Rankless by CCL
2026